Events & Seminars > Event Details

Where:

4:00 pm
Room 303, Chemistry Building

Redesigning Escherichia coli to Produce 1,3-Propanediol at Commercial Scale

Speaker:

Professor Nigel S. Dunn-Coleman
President and CEO AlerGenetica SL, Tenerife, Canary Islands, Spain

Hosted by: Professor Charles Grisham

Dunn-Coleman biosketch

Professor Nigel S. Dunn-Coleman

President and CEO AlerGenetica SL, Tenerife, Canary Islands, Spain

Biotechnology affilations
Genencor (a biotechnology subsidiary of DuPont, located in Palo Alto, CA) for 20 years with last role as Research & Development program leader. Also responsible for Genencor’s fungal genomic collaborations and the development of fungal production strains.
DuPont (E. I. du Pont de Nemours and Company) – BIO-PDO (1,3-propanediol) project co-leader. This program won a Presidental Award for Green Chemistry

Academic affiliations
PhD in fungal genetics, University of Manchester (1978)
Postdoctoral research fellow at the University of Glasgow
Postdoctoral research fellow at the University of Virginia (1980-83)
Current affiliation: Visiting professor, University of Manchester (England)
Other relevant experience: DOE-JGI (U.S. Department of Energy Joint Genomics Project) reviewer of sequencing programs

Co-Founder of two biotechnology companies
AlerGenetica SL (www.alergenetica.org) a biopharma start up with the focus on peptide vaccines for fungal allergy.
Aspergillus Expression Systems – a new company developing the filamentous fungus Aspergillus niger as a host system for biotechnology